Combined treatment of diffuse sclerosing osteomyelitis of mandible in children

Diffuse sclerosing osteomyelitis of the jaw (DSO) is a rare and poorly understood disease. Nowadays treatment protocols (steroid or painkillers, corticotomy) do not capable of to get good and stabile results or are associated with the development of potentially serious side effects. The treatment algorithm developed by us, including the course treatment with bisphosphonates, was well tolerated and capable of to get clinical and radiological remission in the case of previous decortication and antibacterial therapy was done. For these reasons, this treatment protocol is not without interest and need of further investigates. The study was approved by the Local Ethics Committee of Russian Children's Clinical Hospital. © 2019 by NMRC PHOI.

Авторы
Kugushev A.Y.1 , Lopatin A.V. 1, 2 , Yasonov S.A. 1 , Sinitsyn D.S.1
Издательство
Фонд поддержки и развития в области детской гематологии, онкологии и иммунологии Врачи, инновации, наука - детям
Номер выпуска
3
Язык
Русский
Страницы
46-53
Статус
Опубликовано
Том
18
Год
2019
Организации
  • 1 Russian Children's Clinical Hospital of the Pirogov, Russian National Research Medical University, Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
  • 2 Рeoples' friendship University of Russia, Moscow, Russian Federation
Ключевые слова
Bisphosphonates; Diffuse sclerosing osteomyelitis
Дата создания
24.12.2019
Дата изменения
24.12.2019
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/55423/
Поделиться

Другие записи